Texas spinout Decisio Health launches its bedside clinical intelligence platform to support healthcare staff in hospitals following a $4.5m series A round.
Decisio Health, a US-based healthcare IT spinout from University of Texas system, has launched its product following a $4.5m series A round backed by the university’s Horizon Fund.
The round was led by Declatex. Decisio had raised an initial $2.5m in February 2016 with a final target of $5m.
UT Horizon Fund was established in 2011to invest in early and mid-stage companies with a link to the university operating in all industry sectors.
Founded in 2013, Decisio Health has created a clinical intelligence platform that provides care staff in hospitals with a display that shows vital trends and lab reports on each patient. The technology provides visual alerts and displays hospital procedures to ensure consistency of care.
The platform is based on research at the university’s Health Science Center at Houston.
Bryan Haardt, chief executive of Decisio Health, said: “By arming clinicians with this information they are able to be more patient-focused and proactive in their decision making via simple, visual and instantaneous access to the most critical patient data and trends.”
